Strategic Shifts in the 2026 Pruritus Drug Market: Beyond Symptom...

bir ses eklendi Health

2026-01-09 09:23:13 -

Strategic Shifts in the 2026 Pruritus Drug Market: Beyond Symptom Relief

The therapeutic landscape for chronic itch has transitioned from broad-spectrum antihistamines to highly specific molecular targeting. In 2026, the focus is squarely on neuro-immune crosstalk, particularly the role of interleukin-31 (IL-31) and the Janus kinase (JAK) pathways. This evolution is a primary driver in recent Pruritus Drug Market analysis, which underscores a declining reliance...

0 Yorumlar 0 hisse senetleri 287 Views 0 önizleme